Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FOMX

Menlo Therapeutics (FOMX) Stock Price, News & Analysis

Menlo Therapeutics logo

About Menlo Therapeutics Stock (NASDAQ:FOMX)

Advanced Chart

Key Stats

Today's Range
$2.99
$2.99
50-Day Range
$2.99
$2.99
52-Week Range
$1.97
$4.84
Volume
N/A
Average Volume
518,350 shs
Market Capitalization
$184.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FOMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Menlo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FOMX Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
How to Watch Local FOX Stations Without Cable
Michael J. Fox Foundation taps Palo Alto AI firm
See More Headlines

FOMX Stock Analysis - Frequently Asked Questions

Menlo Therapeutics Inc. (NASDAQ:FOMX) released its quarterly earnings results on Monday, November, 11th. The specialty pharmaceutical company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.07.

Based on aggregate information from My MarketBeat watchlists, some other companies that Menlo Therapeutics investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Amarin (AMRN), Bristol Myers Squibb (BMY), Sangamo Therapeutics (SGMO), Anavex Life Sciences (AVXL) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
11/11/2019
Today
7/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:FOMX
CIK
1606645
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-100.58%
Return on Assets
-81.39%

Debt

Debt-to-Equity Ratio
0.24
Current Ratio
5.72
Quick Ratio
5.72

Sales & Book Value

Annual Sales
$3.60 million
Price / Sales
51.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.70 per share
Price / Book
1.76

Miscellaneous

Outstanding Shares
61,580,000
Free Float
N/A
Market Cap
$184.12 million
Optionable
Optionable
Beta
1.66
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:FOMX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners